Close
Found 0 results for your search. Showing 0 to 0.
No results could be found for your search.
x Close Search
Close

Publications

End-point definition and trial design to advance tuberculosis vaccine development.
Garcia-Basteiro, AL; WHITE, RG; Tait, D; Schmidt, AC; Rangaka, MX; Quaife, M; Nemes, E; Mogg, R; Hill, PC; Harris, RC; Hanekom, WA; Frick, M; Fiore-Gartland, A; Evans, T; Dagnew, AF; Churchyard, G; Cobelens, F; Behr, MA; Hatherill, M;
2022
European respiratory review, (2022).31 164 10.1183/16000617.0044-2022.
Tuberculosis prevalence: beyond the tip of the iceberg.
HOUBEN, RM G J; Esmail, H; Cobelens, F; Williams, CM L; Coussens, AK;
2022
The Lancet Respiratory medicine, (2022).10 6 10.1016/S2213-2600(22)00184-9.
TBVAX Model.
CLARK, R; MUKANDAVIRE, C; WEERASURIYA, C; Bakker, R; WHITE, RG;
2022
, Zenodo (2022).
Neighbourhood prevalence-to-notification ratios for adult bacteriologically-confirmed tuberculosis reveals hotspots of underdiagnosis in Blantyre, Malawi.
Khundi, M; CARPENTER, JR; CORBETT, EL; FEASEY, HR A; Soko, RN; Nliwasa, M; Twabi, H; Chiume, L; BURKE, RM; HORTON, KC; Dodd, PJ; Cohen, T; MacPherson, P;
2022
PloS one, (2022).17 5 10.1371/journal.pone.0268749.
A crowd of BashTheBug volunteers reproducibly and accurately measure the minimum inhibitory concentrations of 13 antitubercular drugs from photographs of 96-well broth microdilution plates.
Fowler, PW; Wright, C; Spiers, H; Zhu, T; Baeten, EM L; Hoosdally, SW; Gibertoni Cruz, AL; Roohi, A; Kouchaki, S; Walker, TM; Peto, TE A; Miller, G; Lintott, C; Clifton, D; Crook, DW; Walker, AS; Zooniverse Volunteer Community,; CRyPTIC Consortium,;
2022
eLife, (2022).11, 10.7554/eLife.75046.
The global impact of household contact management for children on multidrug-resistant and rifampicin-resistant tuberculosis cases, deaths, and health-system costs in 2019: a modelling study.
Dodd, PJ; Mafirakureva, N; Seddon, JA; MCQUAID, CF;
2022
The Lancet. Global health, (2022).10 7 10.1016/S2214-109X(22)00113-9.
The state of tuberculosis in South Africa: what does the first national tuberculosis prevalence survey teach us?.
AYLES, H; Mureithi, L; Simwinga, M;
2022
The Lancet. Infectious diseases, (2022).22 8 10.1016/s1473-3099(22)00286-9.
Demonstrating multi-country calibration of a tuberculosis model using new history matching and emulation package - <i>hmer</i>.
Scarponi, D; Iskauskas, A; Clark, R; Vernon, I; McKinley, T; Goldstein, M; Mukandavire, C; Deol, A; WEERASURIYA, C; Bakker, R; WHITE, R; MCCREESH, N;
2022
medRxiv (2022). 10.1101/2022.05.13.22275052.
Molecular characterization of drug-resistant Mycobacterium tuberculosis among Filipino patients derived from the national tuberculosis prevalence survey Philippines 2016.
Montoya, JC; Malabad, JC M; Ang, CF; Reyes, LT; Basilio, RP; Lim, DR; Amarillo, ML E; Ama, MC G; PHELAN, JE; HIBBERD, ML; CLARK, TG;
2022
Tuberculosis, (2022).135, 10.1016/j.tube.2022.102211.
Mathematical Modelling for Optimal Vaccine Dose Finding: Maximising Efficacy and Minimising Toxicity.
BENEST, J; Rhodes, S; Evans, TG; WHITE, RG;
2022
Vaccines, (2022).10 5 10.3390/vaccines10050756.